Ultrasound Beams as an Adjunct to Reperfusion Therapy in STEMI

Therapeutic Effect of Ultrasound Beams as an Adjunct to Reperfusion Therapy in STEMI

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02299609

Enrollment

100

Registered

2014-11-24

Start date

2013-01-31

Completion date

2016-02-29

Last updated

2014-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction, ST Elevation Myocardial Infarction

Keywords

C14.280.647.500

Brief summary

Successfully perfused STEMI patients will receive routine transthoracic echocardiography qid for 4 days or placebo. Myocardial function and infarct size will be evaluated at 3 and 6 months.

Detailed description

Patients who had acute STEMI and successfully reperfused by either thrombolytic therapy or primary angioplasty and stenting will be included this study. A basal routine echocardiography will be obtained in all patients after reperfusion therapy. Thereafter, patients will be divided into two groups: 1.Treatment group will receive transthoracic echocardiography using Philips HD11 XE ® for 30 minutes qid for 4 days. 2. Placebo group will have the same Philips HD11 XE ® echo transducer applied for the same time and duration on their chest but with the ultrasound turned-off. Detailed left and right ventricle function as well as performance index and stress-strain imaging will be obtained and analyzed at 3 and 6 months.

Interventions

OTHERUltrasound beams Philips HD11 XE®

Ultrasound beams used during standard echocardiography

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

-Patients presenting within 12 hours of their first ST- elevation myocardial infarction that is successfully reperfused; and completed baseline echocardiographic evaluation and accepted participation in the study

Exclusion criteria

Patients: * With prior ST- elevation myocardial infarction * Patients presenting \>12hrs * Not successfully reperfused * Not completed baseline ECHO evaluation, * Not accepting participation in the study

Design outcomes

Primary

Measure	Time frame	Description
Increase in left ventricular function	At 3 and 6 months	Ultrasound beams during echocardiography application expected to ameliorate the left ventricle function

Secondary

Measure	Time frame	Description
Decrease in infarct size	At 3 and 6 months	Ultrasound beams during echocardiography application expected to decrease infarct size

Countries

Turkey (Türkiye)

Contacts

Primary ContactRamazan Akdemir, MD

rakdemir@yahoo.com00905336020700

Backup ContactRamazan Akdemir, MD

ramazanakdemir@gmail.com00905426427388

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026